$BOMO
bowmo, Inc.

2021 Q4 Form 10-K Financial Statement

#000121390022021280 Filed on April 25, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $51.64K
YoY Change
Gross Profit $150.0K
YoY Change
Gross Profit Margin
Selling, General & Admin $121.3K $502.8K $381.0K
YoY Change -68.18% -24.47% 169.88%
% of Gross Profit 335.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $121.3K $502.8K $381.0K
YoY Change -68.18% -24.47% 169.88%
Operating Profit -$288.3K
YoY Change
Interest Expense -$464.9K -$1.780M -$1.928M
YoY Change -75.89% -27.35% 237.36%
% of Operating Profit
Other Income/Expense, Net $22.38K $0.00
YoY Change
Pretax Income -$586.2K -$1.553M -$1.378M
YoY Change -57.46% -28.89% 93.33%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$586.2K -$1.553M -$1.378M
YoY Change -57.46% -28.89% 93.33%
Net Earnings / Revenue
Basic Earnings Per Share $0.01
Diluted Earnings Per Share -$98.32 -$322.80 -$2.819K
COMMON SHARES
Basic Shares Outstanding 18.15M
Diluted Shares Outstanding 18.15M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.710K $5.710K
YoY Change
Cash & Equivalents $385.00 $5.710K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $37.64K
Other Receivables
Total Short-Term Assets $5.710K $5.710K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $32.31K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $5.710K $5.710K
Total Long-Term Assets $32.31K $0.00
Total Assets $38.02K $5.710K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.85K $326.4K $326.4K
YoY Change -79.82% 0.0% 3.16%
Accrued Expenses $18.60K $1.555M $1.443M
YoY Change -98.71% 7.74% 5.65%
Deferred Revenue $3.11
YoY Change
Short-Term Debt $864.1K $864.1K $1.646M
YoY Change -47.5% -47.5% -15.52%
Long-Term Debt Due $69.99K
YoY Change
Total Short-Term Liabilities $839.9K $2.971M $5.555M
YoY Change -84.88% -46.51% 35.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $839.9K $2.971M $5.555M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $880.3K $2.971M $5.555M
YoY Change -84.15% -46.51% 35.4%
SHAREHOLDERS EQUITY
Retained Earnings -$4.663M
YoY Change
Common Stock $18.15K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00
YoY Change
Treasury Stock Shares $0.00
Shareholders Equity -$842.3K -$2.966M -$576.4K
YoY Change
Total Liabilities & Shareholders Equity $38.02K $5.710K
YoY Change

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$586.2K -$1.553M -$1.378M
YoY Change -57.46% -28.89% 93.33%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$10.07K -$65.29K $0.00
YoY Change 73.64% -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions $21.86K
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 71.00K 0.000
YoY Change 88.83% -100.0%
NET CHANGE
Cash From Operating Activities -10.07K -65.29K 0.000
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 10.00K 71.00K 0.000
Net Change In Cash -70.00 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$10.07K -$65.29K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 czni Preferred Stocks Redemption Premium
PreferredStocksRedemptionPremium
USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 czni Preferred Stock Value5
PreferredStockValue5
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020Q4 us-gaap Assets
Assets
USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
69993 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
USD
CY2020 czni Loss On Debt Litigation
LossOnDebtLitigation
USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2021Q1 czni Stock Issued During Period Value Issued For Extinguishment Of Preferred Stock
StockIssuedDuringPeriodValueIssuedForExtinguishmentOfPreferredStock
USD
CY2020 czni Loss On Debt Litigation
LossOnDebtLitigation
USD
CY2020 czni Gain On New Methodology For Accounting For Debt Conversion Features
GainOnNewMethodologyForAccountingForDebtConversionFeatures
USD
CY2020 czni Debt Discount Elimination
DebtDiscountElimination
USD
CY2020 czni Put Premium Incurred On Stock Settled Debt
PutPremiumIncurredOnStockSettledDebt
USD
CY2020 czni Original Issue Discount Charged Interest Expense
OriginalIssueDiscountChargedInterestExpense
USD
CY2021 czni Increase Decrease In Other Operating Asset
IncreaseDecreaseInOtherOperatingAsset
USD
CY2020 czni Increase Decrease In Other Operating Asset
IncreaseDecreaseInOtherOperatingAsset
USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
USD
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
USD
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
USD
CY2021Q4 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
USD
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2019 czni Weighted Average Price Forfeited Forfeited
WeightedAveragePriceForfeitedForfeited
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2019 czni Weighted Average Fair Value Expired
WeightedAverageFairValueExpired
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
shares
CY2020 czni Weighted Average Price Forfeited Forfeited
WeightedAveragePriceForfeitedForfeited
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2020 czni Weighted Average Fair Value Expired
WeightedAverageFairValueExpired
CY2020 czni Gain On Transfer Of Methodology To Put Premium
GainOnTransferOfMethodologyToPutPremium
USD
CY2020 czni Interest Expense For Incursion Of Put Premium To Stock Settled Debt
InterestExpenseForIncursionOfPutPremiumToStockSettledDebt
USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD

Files In Submission

Name View Source Status
0001213900-22-021280-index-headers.html Edgar Link pending
0001213900-22-021280-index.html Edgar Link pending
0001213900-22-021280.txt Edgar Link pending
0001213900-22-021280-xbrl.zip Edgar Link pending
czni-20211231.xsd Edgar Link pending
czni-20211231_cal.xml Edgar Link unprocessable
czni-20211231_def.xml Edgar Link unprocessable
czni-20211231_lab.xml Edgar Link unprocessable
czni-20211231_pre.xml Edgar Link unprocessable
f10k2021ex31_cruzaniinc.htm Edgar Link pending
f10k2021ex32_cruzaniinc.htm Edgar Link pending
f10k2021_cruzaniinc.htm Edgar Link pending
f10k2021_cruzaniinc_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending